This episode is the first half of an expert discussion on treatments for COVID-19 in the hospital setting. The episode covers the latest information on the use of convalescent plasma and remdesivir, including the available efficacy data, when to administer treatment, and potential toxicities to expect. Claim your credit at pce.is/COV19.
In the global effort to address the COVID-19 pandemic, healthcare practitioners need to stay up to date as the Emergency Use Authorization (EUAs) for treatments and vaccines change rapidly. This 6-part podcast series opens with a discussion of how EUAs work and how they are different from full approval. In the subsequent episodes, experts explain the latest evidence-based information on inpatient and outpatient antiviral treatments, the most recent information on available vaccines, and how the emerging SARS-CoV-2 variants impact our COVID-19 toolbox.This episode is the first half of an expert discussion on treatments for COVID-19 in the hospital setting. The episode covers the latest information on the use of convalescent plasma and remdesivir, including the available efficacy data, when to administer treatment, and potential toxicities to expect.Claim your credit at pce.is/COV19.